{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:51:57Z","timestamp":1761897117650,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["grants 81570884, 81770961"],"award-info":[{"award-number":["grants 81570884, 81770961"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the SMC-ChenXing Yong Scholar Program","award":["2016, Class A"],"award-info":[{"award-number":["2016, Class A"]}]},{"name":"the Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant","award":["20152223"],"award-info":[{"award-number":["20152223"]}]},{"name":"Innovation Fund for Translational Medicine","award":["15ZH1005"],"award-info":[{"award-number":["15ZH1005"]}]},{"name":"Ph.D. Programs Foundation of Shanghai JiaoTong University School of Medicine","award":["BXJ201834"],"award-info":[{"award-number":["BXJ201834"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Orbital\/periorbital plexiform neurofibroma (OPPN) can compromise physical appearance and visual function. However, the clinical characteristics and <jats:italic>NF1<\/jats:italic> mutation landscape in patients with heritable OPPN have not been reported.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The medical charts of 26 Chinese patients with OPPN from 12 families were reviewed. Mutation analysis of the entire coding region and flanking splice sites of the <jats:italic>NF1<\/jats:italic> gene was performed using next-generation sequencing (NGS). Novel <jats:italic>NF1<\/jats:italic> mutations were confirmed by Sanger sequencing.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to the parental generation, a significantly larger proportion of OPPN patients in the successive generation presented with earlier onset (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), amblyopia (<jats:italic>p<\/jats:italic>\u2009=\u20090.034), motility disorders (<jats:italic>p<\/jats:italic>\u2009=\u20090.009) and bony orbital expansion (<jats:italic>p<\/jats:italic>\u2009=\u20090.019). Six novel <jats:italic>NF1<\/jats:italic> mutations were identified in 11 (91.67%) families, including 6 (42.9%) single-base substitutions, 4 (28.5%) splicing mutations, 3 (21.4%) frameshift deletions, and 1 (7.14%) intron mutation.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The successive generation of OPPN patients presented with earlier onset and exhibited more severe ocular signs than did their parents or grandparents. Special attention should be paid to successive generations of OPPN patients. Considering that 6 mutations were novel, comprehensive <jats:italic>NF1<\/jats:italic> mutation analysis is required or necessary or proposed for genetic counselling.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12881-019-0877-9","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:05:02Z","timestamp":1568804702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital\/periorbital plexiform Neurofibromatosis type 1"],"prefix":"10.1186","volume":"20","author":[{"given":"Peiwei","family":"Chai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxiu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuandi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9135-0940","authenticated-orcid":false,"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"877_CR1","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1086\/301803","volume":"62","author":"E Ars","year":"1998","unstructured":"Ars E, et al. A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene. Am J Hum Genet. 1998;62:834\u201341. \n                    https:\/\/doi.org\/10.1086\/301803\n                    \n                  .","journal-title":"Am J Hum Genet"},{"key":"877_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/(SICI)1096-8628(19991008)86:4<328::AID-AJMG6>3.0.CO;2-O","volume":"86","author":"A Buske","year":"1999","unstructured":"Buske A, et al. Recurrent NF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1). Am J Med Genet. 1999;86:328\u201330.","journal-title":"Am J Med Genet"},{"key":"877_CR3","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1200\/JCO.2016.71.7199","volume":"35","author":"J Campian","year":"2017","unstructured":"Campian J, Gutmann DH. CNS tumors in Neurofibromatosis. J Clin Oncol. 2017;35:2378\u201385. \n                    https:\/\/doi.org\/10.1200\/JCO.2016.71.7199\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"877_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jaad.2015.05.021","volume":"73","author":"N Duman","year":"2015","unstructured":"Duman N, Elmas M. Dermoscopy of cutaneous neurofibromas associated with neurofibromatosis type 1. J Am Acad Dermatol. 2015;73:529\u201331. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2015.05.021\n                    \n                  .","journal-title":"J Am Acad Dermatol"},{"key":"877_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00002341-199612000-00006","volume":"12","author":"SR Farris","year":"1996","unstructured":"Farris SR, Grove AS Jr. Orbital and eyelid manifestations of neurofibromatosis: a clinical study and literature review. Ophthal Plast Reconstr Surg. 1996;12:245\u201359.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"877_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ophtha.2016.09.020","volume":"124","author":"RA Avery","year":"2017","unstructured":"Avery RA, et al. Orbital\/periorbital plexiform Neurofibromas in children with Neurofibromatosis type 1: multidisciplinary recommendations for care. Ophthalmology. 2017;124:123\u201332. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2016.09.020\n                    \n                  .","journal-title":"Ophthalmology"},{"key":"877_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/archopht.1988.01060130790007","volume":"106","author":"JT Coyle","year":"1988","unstructured":"Coyle JT. Orbital optic glioma in neurofibromatosis. Arch Ophthalmol. 1988;106:720\u20131.","journal-title":"Arch Ophthalmol"},{"key":"877_CR8","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1001\/archopht.1987.01060120087032","volume":"105","author":"SR Seiff","year":"1987","unstructured":"Seiff SR, et al. Orbital optic glioma in neurofibromatosis. Magnetic resonance diagnosis of perineural arachnoidal gliomatosis. Arch Ophthalmol. 1987;105:1689\u201392.","journal-title":"Arch Ophthalmol"},{"key":"877_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.0022-202X","volume":"125","author":"C Consoli","year":"2005","unstructured":"Consoli C, et al. Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. J Invest Dermatol. 2005;125:463\u20136. \n                    https:\/\/doi.org\/10.1111\/j.0022-202X\n                    \n                   23834.x (2005).","journal-title":"J Invest Dermatol"},{"issue":"10","key":"877_CR10","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3390\/ijms18102071","volume":"18","author":"Francesco Bonatti","year":"2017","unstructured":"Bonatti F, et al. Patterns of novel alleles and genotype\/phenotype correlations resulting from the analysis of 108 previously undetected mutations in patients affected by Neurofibromatosis type I. Int J Mol Sci. 2017;18. \n                    https:\/\/doi.org\/10.3390\/ijms18102071\n                    \n                  .","journal-title":"International Journal of Molecular Sciences"},{"key":"877_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/neuonc\/nov200","volume":"18","author":"JO Blakeley","year":"2016","unstructured":"Blakeley JO, Plotkin SR. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro-Oncology. 2016;18:624\u201338. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nov200\n                    \n                  .","journal-title":"Neuro-Oncology"},{"key":"877_CR12","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.21873\/anticanres.11010","volume":"36","author":"C Yapijakis","year":"2016","unstructured":"Yapijakis C, Adamopoulou M, Tasiouka K, Voumvourakis C, Stranjalis G. Mutation screening of Her-2, N-ras and Nf1 genes in brain tumor biopsies. Anticancer Res. 2016;36:4607\u201311. \n                    https:\/\/doi.org\/10.21873\/anticanres.11010\n                    \n                  .","journal-title":"Anticancer Res"},{"key":"877_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","volume":"45","author":"Neurofibromatosis","year":"1988","unstructured":"Neurofibromatosis. Conference statement. National Institutes of Health consensus development conference. Arch Neurol. 1988;45:575\u20138.","journal-title":"Arch Neurol"},{"key":"877_CR14","doi-asserted-by":"publisher","first-page":"e0188104","DOI":"10.1371\/journal.pone.0188104","volume":"12","author":"C Colabella","year":"2017","unstructured":"Colabella C, et al. Merging FT-IR and NGS for simultaneous phenotypic and genotypic identification of pathogenic Candida species. PLoS One. 2017;12:e0188104. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0188104\n                    \n                  .","journal-title":"PLoS One"},{"key":"877_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jocn.2015.12.034","volume":"31","author":"S Banerjee","year":"2016","unstructured":"Banerjee S, et al. A novel mutation in NF1 is associated with diverse intra-familial phenotypic variation and astrocytoma in a Chinese family. J Clin Neurosci. 2016;31:182\u20134. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2015.12.034\n                    \n                  .","journal-title":"J Clin Neurosci"},{"key":"877_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejmg.2016.11.001","volume":"60","author":"F Cali","year":"2017","unstructured":"Cali F, et al. Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using ion torrent PGM platform. Eur J Med Genet. 2017;60:93\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ejmg.2016.11.001\n                    \n                  .","journal-title":"Eur J Med Genet"},{"key":"877_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.pediatrneurol","volume":"48","author":"JM Ko","year":"2013","unstructured":"Ko JM, Sohn YB, Jeong SY, Kim HJ, Messiaen LM. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1. Pediatr Neurol. 2013;48:447\u201353. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol\n                    \n                   02.004 (2013).","journal-title":"Pediatr Neurol"},{"key":"877_CR18","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1007\/s13277-016-4808-5","volume":"37","author":"Z Li","year":"2016","unstructured":"Li Z, Yu X, Shen J. ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers. Tumour Biol. 2016;37:5657\u201361. \n                    https:\/\/doi.org\/10.1007\/s13277-016-4808-5\n                    \n                  .","journal-title":"Tumour Biol"},{"key":"877_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2350-13-98","volume":"13","author":"T Mussotter","year":"2012","unstructured":"Mussotter T, et al. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions. BMC Med Genet. 2012;13:98. \n                    https:\/\/doi.org\/10.1186\/1471-2350-13-98\n                    \n                  .","journal-title":"BMC Med Genet"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-019-0877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-019-0877-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-019-0877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T23:20:00Z","timestamp":1600298400000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-019-0877-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1186\/s12881-019-0877-9","relation":{},"ISSN":["1471-2350"],"issn-type":[{"type":"electronic","value":"1471-2350"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"10 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for this study was obtained from Shanghai Jiaotong University. For all samples, only non-identifiable information is presented. Written, informed consent was obtained for all involved patients. Informed consent was obtained from all patients or their guardians at the follow-up visit.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written, informed consent was obtained for all involved patients. A form letter containing the carrier screening agreement for children younger than 18\u2009years old was signed by their parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}